At the Blackmores Institute Symposium today, Chief Executive Officer of Complementary Medicines Australia (CMA), Mr Carl Gibson, welcomed results from a University of Sydney study1, published in the New England Journal of Medicine, which show that vitamin B3 (nicotinamide) can cut the risk of new skin cancers by 23 per cent.

Read the release here